What's new in Shock, June 2006?
Moldawer
Lyle L
LL
Department of Surgery, University of Florida College of Medicine, Gainesville, FL, USA.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D004768:Enterotoxins / Q000008:administration & dosage / Q000633:toxicity; D024243:HMGB1 Protein / Q000097:blood; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000633:toxicity; D051379:Mice; D010506:Periodicals as Topic; D011237:Predictive Value of Tests; D012769:Shock / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D015398:Signal Transduction / Q000187:drug effects; D051193:Toll-Like Receptors / Q000378:metabolism
D000925:Anticoagulants; D015415:Biomarkers; D016207:Cytokines; D004768:Enterotoxins; D024243:HMGB1 Protein; D008070:Lipopolysaccharides; D051193:Toll-Like Receptors; C031818:enterotoxin B, staphylococcal